Carsten Friedrich

1.7k total citations
59 papers, 706 citations indexed

About

Carsten Friedrich is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Neurology. According to data from OpenAlex, Carsten Friedrich has authored 59 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 18 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Neurology. Recurrent topics in Carsten Friedrich's work include Glioma Diagnosis and Treatment (31 papers), Pituitary Gland Disorders and Treatments (18 papers) and Growth Hormone and Insulin-like Growth Factors (12 papers). Carsten Friedrich is often cited by papers focused on Glioma Diagnosis and Treatment (31 papers), Pituitary Gland Disorders and Treatments (18 papers) and Growth Hormone and Insulin-like Growth Factors (12 papers). Carsten Friedrich collaborates with scholars based in Germany, Switzerland and United States. Carsten Friedrich's co-authors include Stefan Rutkowski, Katja von Hoff, Torsten Pietsch, Peter Eades, André O. von Bueren, Monika Warmuth‐Metz, Nicolas U. Gerber, Keith Nesbitt, Robert Kwiecien and Joachim Kuehl and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Carsten Friedrich

56 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carsten Friedrich Germany 15 390 236 142 127 92 59 706
Jacques Champier France 18 375 1.0× 162 0.7× 134 0.9× 125 1.0× 125 1.4× 46 866
Mariam Aboian United States 18 476 1.2× 266 1.1× 233 1.6× 183 1.4× 29 0.3× 79 1.4k
Yu‐Chuan Hu China 18 396 1.0× 54 0.2× 162 1.1× 131 1.0× 64 0.7× 32 1.2k
Shintaro Fukushima Japan 16 600 1.5× 265 1.1× 226 1.6× 165 1.3× 24 0.3× 45 1.1k
W Papierz Poland 17 308 0.8× 299 1.3× 185 1.3× 93 0.7× 49 0.5× 83 966
H. Kolles Germany 10 228 0.6× 69 0.3× 126 0.9× 71 0.6× 28 0.3× 23 425
Martin Sill Germany 23 796 2.0× 678 2.9× 187 1.3× 334 2.6× 106 1.2× 71 1.8k
Phedias Diamandis Canada 22 295 0.8× 571 2.4× 158 1.1× 137 1.1× 13 0.1× 60 1.6k
Peter C. Burger Switzerland 3 714 1.8× 312 1.3× 337 2.4× 250 2.0× 51 0.6× 5 1.3k
Barbara Bobek‐Billewicz Poland 15 205 0.5× 56 0.2× 63 0.4× 108 0.9× 18 0.2× 66 790

Countries citing papers authored by Carsten Friedrich

Since Specialization
Citations

This map shows the geographic impact of Carsten Friedrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Friedrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Friedrich more than expected).

Fields of papers citing papers by Carsten Friedrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Friedrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Friedrich. The network helps show where Carsten Friedrich may publish in the future.

Co-authorship network of co-authors of Carsten Friedrich

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Friedrich. A scholar is included among the top collaborators of Carsten Friedrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Friedrich. Carsten Friedrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Witte, Julian, et al.. (2025). Economics of hypothalamic obesity in patients with craniopharyngioma and other rare sellar/suprasellar tumors. The European Journal of Health Economics. 26(9). 1557–1567. 1 indexed citations
2.
Özyurt, Jale, et al.. (2024). Fatigue in patients with hypothalamic syndrome – A cross-sectional analysis of the German childhood-onset craniopharyngioma cohort. SHILAP Revista de lepidopterología. 4. 100174–100174. 3 indexed citations
3.
Friedrich, Carsten, et al.. (2024). Vascular Morbidity and Mortality in Craniopharyngioma Patients—A Scoping Review. Cancers. 16(6). 1099–1099. 6 indexed citations
4.
Witte, Julian, Bastian Surmann, Manuel Batram, et al.. (2024). Hypothalamic obesity: Epidemiology in rare sellar/suprasellar tumors—A German claims database analysis. Journal of Neuroendocrinology. 36(12). e13439–e13439. 4 indexed citations
5.
Frisch, Sabine, Sarah Peters, Carsten Friedrich, et al.. (2024). Outcome After Modern Proton Beam Therapy in Childhood Craniopharyngioma: Results of the Prospective Registry Study KiProReg. International Journal of Radiation Oncology*Biology*Physics. 120(1). 137–148. 12 indexed citations
6.
Boekhoff, Svenja, et al.. (2023). Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents. Journal of Neuro-Oncology. 163(3). 555–563. 1 indexed citations
7.
Boekhoff, Svenja, Katrin Scheinemann, Freimut H. Schilling, et al.. (2023). Perinatally diagnosed congenital craniopharyngiomas in the KRANIOPHARYNGEOM trials. Endocrine Connections. 12(12). 4 indexed citations
8.
Friedrich, Carsten, Svenja Boekhoff, Gabriele Calaminus, et al.. (2023). Outcome after proton beam therapy versus photon-based radiation therapy in childhood-onset craniopharyngioma patients—results of KRANIOPHARYNGEOM 2007. Frontiers in Oncology. 13. 1180993–1180993. 16 indexed citations
9.
Hagel, Christian, Martin Mynarek, Denise Obrecht, et al.. (2022). Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial. European Journal of Cancer. 164. 30–38. 7 indexed citations
10.
Gessi, Marco, Nicolas U. Gerber, Carsten Friedrich, et al.. (2021). Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial. Neuro-Oncology. 24(1). 127–137. 9 indexed citations
11.
Peng, Junxiang, Svenja Boekhoff, Maria Eveslage, et al.. (2021). Nuchal Skinfold Thickness in Pediatric Brain Tumor Patients. Frontiers in Endocrinology. 12. 772856–772856. 1 indexed citations
12.
Boekhoff, Svenja, Brigitte Bison, Maria Eveslage, et al.. (2021). Cerebral Infarction in Childhood-Onset Craniopharyngioma Patients: Results of KRANIOPHARYNGEOM 2007. Frontiers in Oncology. 11. 698150–698150. 15 indexed citations
13.
Ottensmeier, Holger, Paul G. Schlegel, Matthias Eyrich, et al.. (2020). Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment. PLoS ONE. 15(1). e0227693–e0227693. 13 indexed citations
14.
Friedrich, Carsten, Tarek Shalaby, Christoph Oehler, et al.. (2017). Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response. Child s Nervous System. 33(9). 1463–1471. 4 indexed citations
15.
Nepal‬, ‪Surya, et al.. (2016). KEY MANAGEMENT SERVICE: ENABLING SECURE SHARING AND DELETING OF DOCUMENTS ON PUBLIC CLOUDS. 4(2). 15–31. 2 indexed citations
16.
Nowak, Johannes, Torsten Pietsch, Bálint Alkonyi, et al.. (2015). Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified. Neuro-Oncology. 17(8). 1157–1165. 22 indexed citations
17.
Bueren, André O. von, Carsten Friedrich, Katja von Hoff, et al.. (2015). Metastatic medulloblastoma in adults: Outcome of patients treated according to the HIT2000 protocol. European Journal of Cancer. 51(16). 2434–2443. 26 indexed citations
18.
Pompe, Raisa S., André O. von Bueren, Martin Mynarek, et al.. (2015). Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy. European Journal of Cancer. 51(17). 2634–2642. 32 indexed citations
19.
Friedrich, Carsten, André O. von Bueren, Katja von Hoff, et al.. (2012). Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre study. European Journal of Cancer. 49(4). 893–903. 66 indexed citations
20.
Friedrich, Carsten, André O. von Bueren, Katja von Hoff, et al.. (2012). Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro-Oncology. 15(2). 224–234. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Champier Breakdown of academic impact, for papers by Mariam Aboian Breakdown of academic impact, for papers by Yu‐Chuan Hu Breakdown of academic impact, for papers by Shintaro Fukushima Breakdown of academic impact, for papers by W Papierz Breakdown of academic impact, for papers by H. Kolles Breakdown of academic impact, for papers by Martin Sill Breakdown of academic impact, for papers by Phedias Diamandis Breakdown of academic impact, for papers by Peter C. Burger Breakdown of academic impact, for papers by Barbara Bobek‐Billewicz
Rankless by CCL
2026